Characterization of cancer-induced bone pain: an exploratory study. (Q39850994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Characterization of cancer-induced bone pain: an exploratory study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Gordon Murray

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Lesley A Colvin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Marie Fallon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Barry J A Laird

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Eleanor Clausen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1393-1401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Malignant bone pain: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Breakthrough pain: definition, prevalence and characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Breakthrough pain: characteristics and impact in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Breakthrough pain in cancer patients: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Defining the clinically important difference in pain outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

The McGill Pain Questionnaire: Major properties and scoring methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Worst, average or current pain in the Brief Pain Inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Predictive factors in advanced cancer pain treated only by analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Cancer breakthrough pain characteristics and responses to treatment at a VA medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

The use of fentanyl and alfentanil sprays for episodic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Characterization of breakthrough pain by hospice patients and their caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0961-3

Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.

21 January 2018

1 reference

12 December 2020

A prospective multicenter assessment of the Edmonton staging system for cancer pain

1 reference

12 December 2020

Skeletal complications of malignancy

1 reference

12 December 2020

Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

1 reference

12 December 2020

Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis

1 reference

12 December 2020

Pain assessment: global use of the Brief Pain Inventory

1 reference

12 December 2020

A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain

1 reference

12 December 2020

Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain

1 reference

12 December 2020

Radiotherapy for the palliation of painful bone metastases.

1 reference

12 December 2020

10.1007/S00520-010-0961-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20680354%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference